Biden calls on Congress to ease Senate rules to codify Roe v. Wade

Biden calls on Congress to ease Senate rules to codify Roe v. Wade


A person holds a sign reading “Codify Roe v. Wade” as abortion rights activists protest after the overturning of Roe Vs. Wade by the US Supreme Court, in Downtown Los Angeles, on June 24, 2022.

Frederic J. Brown | AFP | Getty Images

President Joe Biden on Thursday said he would support a suspending the Senate filibuster rule to codify the constitutional right to an abortion as established by the Supreme Court’s landmark 1973 ruling to Roe v. Wade.

His comments represent critical support for suspending a key procedural hurdle that has thus far prevented Senate Democrats from passing legislation that would make the Roe decision federal law. Current Senate rules require the majority party to muster 60 votes to overcome the minority’s attempt to block the advance of a bill, an procedural action known as a filibuster.

“I believe we have to codify Roe v. Wade into law. And the way to do that is to make sure Congress votes to do that,” Biden told reporters in Spain.

But with the Senate split 50-50 between Democrats and Republicans, the GOP has been able to use the filibuster rule to stop the slim Democratic majority from approving abortion bills.

“If the filibuster gets in the way, it’s like voting rights, we provide an exception for this,” Biden said. “We require an exception of the filibuster for this action.”

Biden’s comments come a week after the nation’s highest court overturned 50 years of legal precedent by reversing its original opinion that women have a constitutional right to an abortion. They also mark the first time the president has publicly supported changing the filibuster rules to pass legislation codifying Roe v. Wade into law.

CNBC Politics

Read more of CNBC’s politics coverage:

The court’s controversial ruling last week now grants states the power decide their own abortion laws without worrying about running afoul of the Roe opinion, which had allowed abortions during the first two trimesters of pregnancy.

The president said he’s scheduled to meet with state governors on Friday to discuss their options until Democrats in Congress cement their response. Echoing the belief held by many Democrats, Biden added that the court’s reversal “is a serious, serious problem the Supreme Court has thrust upon the United States.”

“I’m going to do everything in my power I legally can do in terms of protecting abortion, as well as pushing Congress and the public,” he said.

Even Biden’s backing doesn’t mean Democrats will be able to force abortion legislation through the Senate. That’s because, while the filibuster could be changed with a simple majority vote, not all Senate Democrats like the idea of tossing out a way to check future Republican majorities.

Moderate Democrats Sens. Joe Manchin of West Virginia and Kyrsten Sinema of Arizona, for example, have said they are against edits to the filibuster rules.



Source

Investors usually ‘sell in May and go away.’ Why that may not work this year
World

Investors usually ‘sell in May and go away.’ Why that may not work this year

“Sell in May and go away?” Some market participants say it could be better to wait and see this year. The old stock market adage speaks to the phenomenon in which the May-through-October stretch has seasonally borne out to be the worst six-month period of returns for stocks. With traders leaving their desks during the […]

Read More
Jury selection kicks off in Musk v. Altman trial
World

Jury selection kicks off in Musk v. Altman trial

A combination image shows Sam Altman, CEO of OpenAI, during the Asia-Pacific Economic Cooperation (APEC) CEO Summit in San Francisco, California, U.S., on November 16, 2023 and Elon Musk, Chief Executive Officer of SpaceX and Tesla and owner of X, formerly known as Twitter during Viva Technology conference dedicated to innovation and startups at the […]

Read More
Pharma bets a little-known form of cholesterol will underpin its next blockbuster heart drugs
World

Pharma bets a little-known form of cholesterol will underpin its next blockbuster heart drugs

Pharma thinks it’s found the next frontier in preventing heart attacks.  Novartis, Amgen and Eli Lilly are among the drugmakers betting that slashing levels of a particularly bad form of cholesterol could deliver the next blockbusters in cardiology. All three of the pharmaceutical giants are in late-stage trials to test whether drugs that cut Lp(a) […]

Read More